Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

HISPRIL

DIPHENYLPYRALINE HYDROCHLORIDE

Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview HISPRIL is listed in Drugs@FDA under application 011945 (NDA).

Marketing status: Discontinued Active ingredient DIPHENYLPYRALINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 5MG Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview HISPRIL is listed in Drugs@FDA under application 011945 (NDA). Marketing status: Discontinued Active ingredient DIPHENYLPYRALINE HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 5MG Sponsor GLAXOSMITHKLINE Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.